Aug. 20 at 3:25 PM
$GEHC posts strong Q2 results, but why is the stock down 5.4% YTD against industry growth of 6% and S&P 500's 8.8%? 📉
💡 Revenue up 7% YoY to
$5.25B, driven by Imaging and double-digit growth in Pharmaceutical Diagnostics.
📈 Adjusted EPS of 97 cents, solid despite FX and inflation pressures.
🏭 Productivity gains with 150 bps margin expansion highlight operational strength.
Full analysis on GE HealthCare’s growth potential and challenges here 👉 https://www.zacks.com/stock/news/2740343/gehc-positioned-for-growth-with-ai-global-expansion-and-margins?cid=sm-stocktwits-2-2740343-body-8587&ADID=SYND_STOCKTWITS_TWEET_2_2740343_BODY_8587